Man Group
HHS icon

Man Group’s Harte-Hanks HHS Stock Holding History

Man Group’s Portfolio HHS Stock Details HHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,048
Closed -$44K – 2322
2025
Q2 		$44K Sell
11,048
-20,550
-65% -$92K ﹤0.01% 2141
2025
Q1 		$152K Sell
31,598
-1,279
-4% -$6.53K ﹤0.01% 2076
2024
Q4 		$169K Sell
32,877
-1,295
-4% -$8.37K ﹤0.01% 1891
2024
Q3 		$254K Sell
34,172
-23,567
-41% -$185K ﹤0.01% 1806
2024
Q2 		$469K Sell
57,739
-7,798
-12% -$56.9K ﹤0.01% 1705
2024
Q1 		$490K Sell
65,537
-8,302
-11% -$63.2K ﹤0.01% 1787
2023
Q4 		$501K Buy
+73,839
New +$492K ﹤0.01% 1679
2023
Q3 		– Sell
-61,452
Closed -$360K – 1532
2023
Q2 		$337K Buy
+61,452
New +$418K ﹤0.01% 1693
2023
Q1 		– Sell
-30,195
Closed -$333K – 1560
2022
Q4 		$353K Buy
30,195
+13,395
+80% +$148K ﹤0.01% 1603
2022
Q3 		$187K Buy
+16,800
New +$224K ﹤0.01% 1784

Other funds holding HHS

William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
WCM
Westerly Capital Management San Francisco, California $542M AUM 48.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Raffles Associates New York $117M AUM 22.1% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Man Group's HHS Position: Q3 2025 in Review

Man Group sold out of Harte-Hanks (HHS) in Q3 2025, closing a stake of 11,048 shares — an estimated $44K sold.

Man Group first reported a position in HHS in Q3 2022 and held it in 10 quarters. The position peaked at $501K in Q4 2023. 23 funds tracked by Wall St. Rank hold HHS as of Q3 2025.

  • Man Group reported no remaining Harte-Hanks position as of Q3 2025 after selling out during the quarter.
  • Man Group sold 11,048 Harte-Hanks shares in Q3 2025, an estimated $44K.
  • Man Group first reported a position in Harte-Hanks in Q3 2022 and held it in 10 quarters.
  • Man Group's Harte-Hanks position peaked at $501K in Q4 2023.
  • 23 funds tracked by Wall St. Rank held Harte-Hanks as of Q3 2025.

Based on Man Group's 13F filing for Q3 2025, filed 14 Nov 2025.